Levosimendan Ideogen 12
Levosimendan Ideogen 12 is a medicine authorised by Swissmedic under authorisation number 69964. The authorisation holder is IDEOGEN AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 13 August 2026 and the authorisation is limited until 12 August 2031. ATC code C01CX08 places the medicine in the group Cardiac therapy.
| Authorisation number | 69964 |
|---|---|
| Name | Levosimendan Ideogen 12 |
| Full name | Levosimendan Ideogen 12,5 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | IDEOGEN AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | C01CX08 |
| First authorisation | 13 August 2026 |
| Authorisation validity | 12 August 2031 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Levosimendan Ideogen 12,5 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 13 August 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 x 5 ml | Durchstechflasche(n) | C01CX08 | 02.05.2. | A |
| 2 | 4 x 5 ml | Durchstechflasche(n) | C01CX08 | 02.05.2. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Levosimendan Ideogen 12 authorised in Switzerland?
Yes. Levosimendan Ideogen 12 is authorised by Swissmedic under authorisation number 69964, data as of 01 September 2026. The authorisation is limited until 12 August 2031.
Which dispensing category does Levosimendan Ideogen 12 have?
Levosimendan Ideogen 12 is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Levosimendan Ideogen 12?
The authorisation holder is IDEOGEN AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.